U.S. CDC advisers to weigh limits on J&J vaccine due to blood clot issues – Washington Post

FILE PHOTO: A vial and sryinge are seen in front of a displayed Johnson&Johnson logo in this illustration taken January 11, 2021. REUTERS/Dado Ruvic/Illustration

WASHINGTON (Reuters) – Advisers to the U.S. Centers for Disease Control and Prevention will meet on Thursday to consider possible limits on the use of the Johnson & Johnson COVID-19 vaccine because of blood clot issues, the Washington Post reported on Wednesday.

Source: Read Full Article

Related posts:
  1. Health: Aldi, Lidl and Co – antibiotic-resistant germs on to each of the second chicken in the trade confirmed
  2. Virtual reality could cure depression
  3. PCOS Awareness Month 2020: Simple ways to holistically treat the condition
  4. Dulaglutide Tied to Lower Incidence of Erectile Dysfunction in Type 2 Diabetes
Health News Comments Off on U.S. CDC advisers to weigh limits on J&J vaccine due to blood clot issues – Washington Post